627 related articles for article (PubMed ID: 25786175)
1. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals.
Lee J; Zhang T; Hwang I; Kim A; Nitschke L; Kim M; Scott JM; Kamimura Y; Lanier LL; Kim S
Immunity; 2015 Mar; 42(3):431-42. PubMed ID: 25786175
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.
Schlums H; Cichocki F; Tesi B; Theorell J; Beziat V; Holmes TD; Han H; Chiang SC; Foley B; Mattsson K; Larsson S; Schaffer M; Malmberg KJ; Ljunggren HG; Miller JS; Bryceson YT
Immunity; 2015 Mar; 42(3):443-56. PubMed ID: 25786176
[TBL] [Abstract][Full Text] [Related]
3. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
Comeau EM; Holder KA; Fudge NJ; Grant MD
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
[TBL] [Abstract][Full Text] [Related]
5. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
Front Immunol; 2019; 10():687. PubMed ID: 31001281
[TBL] [Abstract][Full Text] [Related]
6. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
Muntasell A; Vilches C; Angulo A; López-Botet M
Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990
[TBL] [Abstract][Full Text] [Related]
7. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
Newhook N; Fudge N; Grant M
Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1
Makwana NB; Foley B; Lee S; Fernandez S; Irish AB; Price P
Eur J Immunol; 2016 Nov; 46(11):2597-2608. PubMed ID: 27562679
[TBL] [Abstract][Full Text] [Related]
9. Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.
Liu LL; Landskron J; Ask EH; Enqvist M; Sohlberg E; Traherne JA; Hammer Q; Goodridge JP; Larsson S; Jayaraman J; Oei VYS; Schaffer M; Taskén K; Ljunggren HG; Romagnani C; Trowsdale J; Malmberg KJ; Béziat V
Cell Rep; 2016 May; 15(5):1088-1099. PubMed ID: 27117418
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency.
Zhang T; Scott JM; Hwang I; Kim S
J Immunol; 2013 Feb; 190(4):1402-6. PubMed ID: 23345329
[TBL] [Abstract][Full Text] [Related]
11. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
Front Immunol; 2021; 12():532484. PubMed ID: 33897679
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
Holder KA; Lajoie J; Grant MD
Front Immunol; 2018; 9():2494. PubMed ID: 30483249
[TBL] [Abstract][Full Text] [Related]
13. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.
Rölle A; Pollmann J; Ewen EM; Le VT; Halenius A; Hengel H; Cerwenka A
J Clin Invest; 2014 Dec; 124(12):5305-16. PubMed ID: 25384219
[TBL] [Abstract][Full Text] [Related]
14. OMIP-039: Detection and analysis of human adaptive NKG2C
Hammer Q; Romagnani C
Cytometry A; 2017 Oct; 91(10):997-1000. PubMed ID: 28715616
[No Abstract] [Full Text] [Related]
15. Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.
Muccio L; Bertaina A; Falco M; Pende D; Meazza R; Lopez-Botet M; Moretta L; Locatelli F; Moretta A; Della Chiesa M
Haematologica; 2016 Mar; 101(3):371-81. PubMed ID: 26659918
[TBL] [Abstract][Full Text] [Related]
16. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
[TBL] [Abstract][Full Text] [Related]
17. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
Muntasell A; López-Montañés M; Vera A; Heredia G; Romo N; Peñafiel J; Moraru M; Vila J; Vilches C; López-Botet M
Eur J Immunol; 2013 Dec; 43(12):3268-78. PubMed ID: 24030638
[TBL] [Abstract][Full Text] [Related]
18. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
Wu Z; Sinzger C; Frascaroli G; Reichel J; Bayer C; Wang L; Schirmbeck R; Mertens T
J Virol; 2013 Jul; 87(13):7717-25. PubMed ID: 23637420
[TBL] [Abstract][Full Text] [Related]
20. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.
Monsiváis-Urenda A; Noyola-Cherpitel D; Hernández-Salinas A; García-Sepúlveda C; Romo N; Baranda L; López-Botet M; González-Amaro R
Eur J Immunol; 2010 May; 40(5):1418-27. PubMed ID: 20201038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
